A rare case of Rosai-Dorfman disease mimicking a malignant lymphoproliferative process and IgG4-related disease.

IF 1.3 Q2 ONCOLOGY
Wspolczesna Onkologia-Contemporary Oncology Pub Date : 2025-01-01 Epub Date: 2025-05-12 DOI:10.5114/wo.2025.150079
Jakub Czerwiński, Mateusz Pysiewicz, Julia Maria Sołek, Aleksandra Opinc, Tadeusz Robak, Joanna Makowska, Marcin Braun
{"title":"A rare case of Rosai-Dorfman disease mimicking a malignant lymphoproliferative process and IgG4-related disease.","authors":"Jakub Czerwiński, Mateusz Pysiewicz, Julia Maria Sołek, Aleksandra Opinc, Tadeusz Robak, Joanna Makowska, Marcin Braun","doi":"10.5114/wo.2025.150079","DOIUrl":null,"url":null,"abstract":"<p><p>Rosai-Dorfman disease (RDD), or sinus histiocytosis with massive lymphadenopathy, is a rare histiocytic disorder that often mimics malignancies and immune-mediated conditions such as IgG4-related disease (IgG4-RD). We report a 73-year-old male with a 2-year history of systemic symptoms, including fever, significant weight loss, and generalised lymphadenopathy, accompanied by strikingly elevated IgG4 levels. Advanced imaging revealed metabolically active lesions in lymph nodes, paranasal sinuses, and bones, complicating the differential diagnosis and raising concerns for malignancy or IgG4-RD. Histopathological examination revealed hallmark features of RDD, including S-100 positivity highlighting emperipolesis and negative CD1a staining, leading to the final diagnosis. The patient initially improved with glucocorticosteroids but achieved sustained symptom resolution with methotrexate, underscoring the potential of antimetabolites for systemic RDD. This case exemplifies the diagnostic and therapeutic challenges of RDD, emphasizing the importance of a multidisciplinary approach and further investigation of targeted therapies for complex and systemic presentations.</p>","PeriodicalId":49354,"journal":{"name":"Wspolczesna Onkologia-Contemporary Oncology","volume":"29 2","pages":"206-209"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224257/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wspolczesna Onkologia-Contemporary Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/wo.2025.150079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rosai-Dorfman disease (RDD), or sinus histiocytosis with massive lymphadenopathy, is a rare histiocytic disorder that often mimics malignancies and immune-mediated conditions such as IgG4-related disease (IgG4-RD). We report a 73-year-old male with a 2-year history of systemic symptoms, including fever, significant weight loss, and generalised lymphadenopathy, accompanied by strikingly elevated IgG4 levels. Advanced imaging revealed metabolically active lesions in lymph nodes, paranasal sinuses, and bones, complicating the differential diagnosis and raising concerns for malignancy or IgG4-RD. Histopathological examination revealed hallmark features of RDD, including S-100 positivity highlighting emperipolesis and negative CD1a staining, leading to the final diagnosis. The patient initially improved with glucocorticosteroids but achieved sustained symptom resolution with methotrexate, underscoring the potential of antimetabolites for systemic RDD. This case exemplifies the diagnostic and therapeutic challenges of RDD, emphasizing the importance of a multidisciplinary approach and further investigation of targeted therapies for complex and systemic presentations.

一个罕见的Rosai-Dorfman病模拟恶性淋巴细胞增生过程和igg4相关疾病的病例。
Rosai-Dorfman病(RDD),或窦性组织细胞增多症伴大量淋巴结病,是一种罕见的组织细胞疾病,通常模仿恶性肿瘤和免疫介导的疾病,如igg4相关疾病(IgG4-RD)。我们报告一位73岁男性患者,有2年的全身性症状史,包括发热、体重明显减轻和全身淋巴结病,并伴有IgG4水平显著升高。晚期影像学显示淋巴结、鼻窦和骨骼的代谢活跃病变,使鉴别诊断复杂化,并引起对恶性肿瘤或IgG4-RD的关注。组织病理学检查显示RDD的标志性特征,包括S-100阳性,突出脾脏增生,CD1a染色阴性,最终诊断为RDD。患者最初使用糖皮质激素得到改善,但使用甲氨蝶呤获得持续的症状缓解,强调了抗代谢物治疗全体性RDD的潜力。该病例体现了RDD的诊断和治疗挑战,强调了多学科方法和进一步研究复杂和系统性表现的靶向治疗的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
22
审稿时长
4-8 weeks
期刊介绍: Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists, radiologists, pathologists, radiotherapists, palliative care specialists, psychologists, nutritionists, and representatives of any other professions, whose interests are related to cancer. Manuscripts devoted to basic research in the field of oncology are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信